- 专利标题： CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME
-
申请号： US17876987申请日： 2022-07-29
-
公开(公告)号： US20230183306A1公开(公告)日： 2023-06-15
- 发明人: David Bechard , Nathalie Chaput , Melanie Desbois
- 申请人： Cytune Pharma , Institut Gustave Roussy (IGR)
- 申请人地址： FR Nantes
- 专利权人： Cytune Pharma,Institut Gustave Roussy (IGR)
- 当前专利权人： Cytune Pharma,Institut Gustave Roussy (IGR)
- 当前专利权人地址： FR Nantes
- 优先权： EP 002066.2 2013.04.19
- 主分类号： C07K14/54
- IPC分类号： C07K14/54 ; A61K38/20 ; G01N33/50 ; A61K47/64 ; C07K14/715
摘要：
The present invention relates to a pharmaceutical composition for treating a cancer or an infection in a subject by administrating an amount of an IL-15 derivative conjugate so as to induce a proliferation of natural killer cells (NK cells) which is the same or higher than the one obtained with high dose of interleukin-2 (HDIL-2); eventually associated with a pharmaceutically acceptable carrier.
信息查询
